Astellas Joins Theravance in Fight against MRSA
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 66 (Table of Contents)
Published: 1 Dec-2005
DOI: 10.3833/pdr.v2005.i66.584 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
At the start of November 2005, Theravance entered into its third ever major licensing agreement, this time with Japanese drugs corporation Astellas...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS